toxylact: a07ca oral rehydratation salt formulations
The first professional lActological database in the word
Oral rehydration salt formulations (ATC A07CA) are standardized mixtures of electrolytes and carbohydrates used to prevent and treat dehydration from acute diarrhea, and they are considered compatible with breastfeeding for both mothers and breastfed infants.atcddd.fhi+3
ATC A07CA overview
ATC subgroup A07CA “Oral rehydration salt formulations” belongs to A07C “Electrolytes with carbohydrates” within the broader A07 antidiarrheal and intestinal antiinfective group. Defined daily doses (DDDs) for A07CA are primarily based on pediatric use, reflecting the key role of ORS in managing dehydration in children.atcddd.fhi+2
Composition and mechanism
A07CA products contain balanced amounts of sodium, chloride, potassium, citrate or bicarbonate, and glucose (sometimes with zinc or albumin tannate), designed to match WHO or similar reduced‑osmolarity formulas. Glucose facilitates sodium and water uptake via sodium–glucose co‑transport in the small intestine, enabling efficient rehydration without exacerbating osmotic diarrhea.who+2
Therapeutic indications
Oral rehydration salts are indicated for the treatment and prevention of mild to moderate dehydration due to acute watery diarrhea, vomiting, and other causes of fluid and electrolyte loss. They do not stop diarrhea itself but replace lost fluids and electrolytes, reducing the risk of hypovolemia and its complications in infants, children, and adults.who+4
Dosing and administration
Typical dosing in adults and older children involves 200–400 ml of ORS after each loose stool, with maximum daily volumes tailored to age and weight. In children, regimens such as 50–100 ml/kg over 3–4 hours for mild to moderate dehydration, plus ongoing “replacement per stool,” are standard, with sachets dissolved in precise volumes of safe water immediately before use.medicalguidelines.msf+4
Pharmacokinetics relevant to lactation
The constituents of A07CA formulas—electrolytes and glucose—are normal dietary and physiological substances absorbed via the gut and handled by usual homeostatic mechanisms. At recommended doses, maternal use does not meaningfully alter breast milk composition beyond what would be expected from normal variations in diet and hydration status.who+3
Maternal safety and adverse effects
ORS is generally safe when reconstituted and used as directed; excessive concentrations, very high intake, or certain comorbidities (for example severe renal impairment) can predispose to overhydration or electrolyte imbalance. Product information notes rare adverse effects such as vomiting, edema (puffy eyelids), and transient blood pressure changes as markers of overhydration, prompting reduction or cessation of ORS.who+3
Lactation safety assessment
Clinical and guideline documents consistently state that ORS can be used safely during pregnancy and lactation, with “no known adverse effects” when used appropriately. Breastfeeding‑specific guidance emphasizes that rehydration solution sachets are the optimal treatment for diarrheal fluid loss in mothers and that they can be taken freely alongside continued breastfeeding.nafdac+4
Use with breastfed infants
In breastfed infants with diarrhea, ORS is given directly to the child while breastfeeding continues; clinical trials show that ORS regimens safely correct dehydration without causing hypernatremia when used according to protocols. Global child‑health guidelines stress that breastfeeding should continue between ORS administrations, as breast milk provides additional fluids, nutrients, and immunologic protection.pubmed.ncbi.nlm.nih+4
Practical recommendations in breastfeeding
For breastfeeding mothers with diarrhea, best practice is to continue breastfeeding, drink according to thirst, and use ORS to replace losses, watching for signs of overhydration such as puffy eyelids. For their infants, caregivers should prepare ORS exactly as directed, offer small frequent sips, and seek medical review if diarrhea persists beyond 2–3 days or if signs of worsening dehydration or systemic illness appear.medicalguidelines.msf+5
Role in toxico‑lactological context
From a toxico‑lactological perspective, A07CA oral rehydration salts are supportive, physiologic therapies rather than xenobiotics and play a central role in reducing morbidity and mortality from diarrheal diseases while preserving breastfeeding. Their favorable safety profile, essential role in dehydration management, and explicit compatibility with lactation make them foundational interventions in any lactation‑conscious approach to diarrheal illness.medicalguidelines.msf+4



